Moody’s lifts Genmab outlook to positive on pipeline progress, debt reduction
In short
Moody’s has raised its outlook for Genmab to positive. The credit rating agency based the upward revision on the company's progress with its development pipeline and ongoing debt reduction.
Key points
- Moody’s has raised its outlook for Genmab to positive.: Moody’s has raised its outlook for Genmab to positive.
- The credit rating agency based the upward revision on the company's progress with its dev…: The credit rating agency based the upward revision on the company's progress with its development pipeline and ongoing debt reduction.